Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenda Wang

Showing results (31-40 of 148) with videos related to

Pageof 15
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2018
Correction: miR-9-5p, miR-124-3p, and miR-132-3p regulate BCL2L11 in tuberous sclerosis complex angiomyolipomaYi Cai, Wenda Wang, Hao Guo, et al.
Experimental and Therapeutic Medicine|April 30, 2020
PTEN inhibitor VO-OHpic suppresses TSC2<sup>-</sup> <sup>/</sup> <sup>-</sup> MEFs proliferation by excessively inhibiting autophagy via the PTEN/PRAS40 pathwayWenda Wang, Xu Wang, Hao Guo, et al.
Fitoterapia|July 30, 2018
Heterocyclic pyrrolizinone and indolizinones derived from natural lactam as potential antifungal agentsShuangshuang Wang, Longzhu Bao, Wenda Wang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 16, 2018
miR-9-5p, miR-124-3p, and miR-132-3p regulate BCL2L11 in tuberous sclerosis complex angiomyolipomaYi Cai, Wenda Wang, Hao Guo, et al.
Journal of Biochemical and Molecular Toxicology|August 25, 2025
Knockdown of CDKN1A Suppresses the IL-17 Pathway to Inhibit Oxidative Stress and Alleviate Autism Spectrum DisorderWenda Wang, Qiujin Lin, Liru Liu, et al.
European Urology Open Science|January 16, 2026
Renal Function Outcomes in Tuberous Sclerosis Complex Patients Receiving Everolimus for Renal AngiomyolipomaZhangcheng Liao, Wenda Wang, Yang Zhao, et al.
Heliyon|August 22, 2024
PMEL is a predictive biomarker for mTORC1 inhibitor treatment of renal angiomyolipoma in tuberous sclerosis complex patientsDongxu Qiu, Zhan Wang, Xu Wang, et al.
Journal of Clinical Pharmacy and Therapeutics|March 1, 2022
Analysis of serum lipid parameters predicting lipid metabolic disorders in TSC-AML patients with treatment of mTOR inhibitorsWenda Wang, Zhan Wang, Yang Zhao, et al.
Neuroreport|February 15, 2020
Event-related potential correlates of auditory feedback control of vocal production in experienced singersXiuqin Wu, Baofeng Zhang, Lirao Wei, et al.
Interdisciplinary Sciences, Computational Life Sciences|March 27, 2024
BDM: An Assessment Metric for Protein Complex Structure Models Based on Distance Difference MatrixJiaqi Zhai, Wenda Wang, Ranxi Zhao, et al.
Pageof 15

Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 20, 2018
Correction: miR-9-5p, miR-124-3p, and miR-132-3p regulate BCL2L11 in tuberous sclerosis complex angiomyolipomaYi Cai, Wenda Wang, Hao Guo, et al.
Experimental and Therapeutic Medicine|April 30, 2020
PTEN inhibitor VO-OHpic suppresses TSC2<sup>-</sup> <sup>/</sup> <sup>-</sup> MEFs proliferation by excessively inhibiting autophagy via the PTEN/PRAS40 pathwayWenda Wang, Xu Wang, Hao Guo, et al.
Fitoterapia|July 30, 2018
Heterocyclic pyrrolizinone and indolizinones derived from natural lactam as potential antifungal agentsShuangshuang Wang, Longzhu Bao, Wenda Wang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 16, 2018
miR-9-5p, miR-124-3p, and miR-132-3p regulate BCL2L11 in tuberous sclerosis complex angiomyolipomaYi Cai, Wenda Wang, Hao Guo, et al.
Journal of Biochemical and Molecular Toxicology|August 25, 2025
Knockdown of CDKN1A Suppresses the IL-17 Pathway to Inhibit Oxidative Stress and Alleviate Autism Spectrum DisorderWenda Wang, Qiujin Lin, Liru Liu, et al.
European Urology Open Science|January 16, 2026
Renal Function Outcomes in Tuberous Sclerosis Complex Patients Receiving Everolimus for Renal AngiomyolipomaZhangcheng Liao, Wenda Wang, Yang Zhao, et al.
Heliyon|August 22, 2024
PMEL is a predictive biomarker for mTORC1 inhibitor treatment of renal angiomyolipoma in tuberous sclerosis complex patientsDongxu Qiu, Zhan Wang, Xu Wang, et al.
Journal of Clinical Pharmacy and Therapeutics|March 1, 2022
Analysis of serum lipid parameters predicting lipid metabolic disorders in TSC-AML patients with treatment of mTOR inhibitorsWenda Wang, Zhan Wang, Yang Zhao, et al.
Neuroreport|February 15, 2020
Event-related potential correlates of auditory feedback control of vocal production in experienced singersXiuqin Wu, Baofeng Zhang, Lirao Wei, et al.
Interdisciplinary Sciences, Computational Life Sciences|March 27, 2024
BDM: An Assessment Metric for Protein Complex Structure Models Based on Distance Difference MatrixJiaqi Zhai, Wenda Wang, Ranxi Zhao, et al.
Pageof 15